Medivis scores FDA clearance for AR platform

Augmented reality (AR) technology company Medivis has received U.S. Food and Drug Administration (FDA) 510(k) clearance for SurgicalAR, its AR platform for surgical applications.

SurgicalAR integrates AR technology, artificial intelligence, and computer vision to enable clinicians to examine holographic medical images directly on corresponding patient anatomy during surgery. The advanced surgical visualization the platform offers may help minimize surgical complications, improve patient outcomes, and lower healthcare costs, the company said.